Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TFP vs ESP on C/S
NCT05117307Not yet recruiting
- Sponsor
- Erzurum City Hospital
- Start
- Dec 2025
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of bupivacaine in postoperative pain (2 arms), sponsored by Erzurum City Hospital. Primary endpoint: Opioid Consumption at 24 hours. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05117307.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05117307.